Physicians Prescriptions

ACE INHIBITORS MAY NOT PROVIDE FURTHER BENEFIT IN CORONARY ARTERY DISEASE

According to results from the recent Prevention of Events with Angiotensin Converting Enzyme Inhibition (PEACE) trial, no benefit is gained by the addition of an angiotensin-converting enzyme (ACE) inhibitor to modern conventional therapy in patients suffering from stable coronary heart disease and preserved left ventricular function and in whom the rate of cardiovascular events is lower than in previous trials of ACE inhibitors in persons with vascular disease. Specifically, the addition of an ACE inhibitor p...